Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Jun 07, 2024 11:55am
187 Views
Post# 36077734

RE:Warrants and options expiring

RE:Warrants and options expiring
My dream scenario is
- TLT gets the 540, 630 and 720 data in the next month or two
- it looks great with durable response
- spikes price to over 0.35
- warrants are redeemed for 20m in cash (although dilutes stock a bit, sigh)
- no more PPs for a while
- fast roll on phase 1 with the cash infusion.

But not likely. Sigh.

Just out of curiousity, 0.35 is a break even strike price on the warrants. But what price would stock have to be to be worth exercising?

67 million is a lot of shares.

Let's say that the share price is around 0.37. That means that you could redeem the warrants and theoretically sell them immediately for 0.37 and make a tiny profit. But that number of shares would crash the prices so you wouldn't sell or wouldn't even bother exercising warrants?

Just curious even though none of it likely to happen.



<< Previous
Bullboard Posts
Next >>